146 related articles for article (PubMed ID: 3011263)
1. Immunomodulating activity in supernatants from EBV immortalized lymphocytes.
Blazar BA; Sutton LM; Strome M
Cancer Immunol Immunother; 1986; 22(1):62-7. PubMed ID: 3011263
[TBL] [Abstract][Full Text] [Related]
2. B-cell-derived interleukin 1 (IL-1)-like factor. I. Relationship of production of IL-1-like factor to accessory cell function of Epstein-Barr virus-transformed human B-lymphoblast lines.
Matsushima K; Kuang YD; Tosato G; Hopkins SJ; Oppenheim JJ
Cell Immunol; 1985 Sep; 94(2):406-17. PubMed ID: 2992808
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
Tosato G; Gerrard TL; Goldman NG; Pike SE
J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
[TBL] [Abstract][Full Text] [Related]
4. Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus.
Gordon J; Ley SC; Melamed MD; Aman P; Hughes-Jones NC
J Exp Med; 1984 May; 159(5):1554-9. PubMed ID: 6325575
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin production in cultures of pokeweed mitogen stimulated human peripheral blood mononuclear cells requires interaction of interleukin 2 with the B cells.
Ceuppens JL; Stevens EA
Cell Immunol; 1986 Mar; 98(1):1-7. PubMed ID: 3017579
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and responses of EBV immortalized B cells from periodontal disease patients.
Celenligil H; Ebersole JL
Oral Dis; 1997 Dec; 3(4):262-71. PubMed ID: 9643223
[TBL] [Abstract][Full Text] [Related]
7. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
8. Induction of B cell responsiveness to growth factors by Epstein-Barr virus conversion: comparison of endogenous factors and interleukin-1.
Blazar BA; Murphy AM
Clin Exp Immunol; 1990 Apr; 80(1):62-8. PubMed ID: 2157568
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.
Yokoi T; Miyawaki T; Yachie A; Kato K; Kasahara Y; Taniguchi N
Immunology; 1990 May; 70(1):100-5. PubMed ID: 2162322
[TBL] [Abstract][Full Text] [Related]
10. Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line.
Scala G; Kuang YD; Hall RE; Muchmore AV; Oppenheim JJ
J Exp Med; 1984 Jun; 159(6):1637-52. PubMed ID: 6327874
[TBL] [Abstract][Full Text] [Related]
11. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells.
Tosato G; Tanner J; Jones KD; Revel M; Pike SE
J Virol; 1990 Jun; 64(6):3033-41. PubMed ID: 2159561
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
[TBL] [Abstract][Full Text] [Related]
13. Autocrine growth of human B lymphocytes: maintained response to autostimulatory factors is the special feature of immortalization by Epstein-Barr virus--a hypothesis.
Gordon J; Guy G; Walker L; Nathan P; Exley R; Clemens M
Med Oncol Tumor Pharmacother; 1986; 3(3-4):269-73. PubMed ID: 3027466
[TBL] [Abstract][Full Text] [Related]
14. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
Sherris D; Stohl W; Mayer L
J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
[TBL] [Abstract][Full Text] [Related]
15. IgE receptors on human lymphocytes. III. Expression of IgE receptors on mitogen-stimulated human mononuclear cells.
Delespesse G; Sarfati M; Rubio-Trujillo M; Wolowiec T
Eur J Immunol; 1986 Sep; 16(9):1043-7. PubMed ID: 3019705
[TBL] [Abstract][Full Text] [Related]
16. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
18. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
19. Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.
Blazar BA; Sutton LM; Strome M
Cancer Res; 1983 Oct; 43(10):4562-8. PubMed ID: 6309371
[TBL] [Abstract][Full Text] [Related]
20. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines.
Bonnefoy JY; Defrance T; Peronne C; Menetrier C; Rousset F; Pène J; De Vries JE; Banchereau J
Eur J Immunol; 1988 Jan; 18(1):117-22. PubMed ID: 2831064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
